The SynCorp Saga: Books 1-3

Product Information

Dr. Arvind has obtained his MBA degree from the University of Birmingham. He completed his FRCP & MRCP from the Royal Colleges of Physicians, London & Glasgow, his MD from Bangalore Medical College and MBBS from St. John’s Medical College.

Wiviott SD, et al. (2019) Dapagliflozin and cardiovascular outcomes in type-2 diabetes [article and supplementary appendix]. NEJM, 380(4):347–57. Rubin, Rebecca (10 December 2020). "After Christopher Nolan's Explosive Remarks, Could Warner Bros. Lose Its Superstar Director?". Variety. Archived from the original on 11 December 2020 . Retrieved 11 December 2020. The Prestige (2006)". Box Office Mojo. Archived from the original on 21 June 2009 . Retrieved 3 January 2013. Interstellar (2014)". Box Office Mojo. Archived from the original on 7 September 2020 . Retrieved 20 August 2020. Batman Begins (2005)". Box Office Mojo. Archived from the original on 24 June 2020 . Retrieved 20 August 2020.Baxdrostat represents a potentially leading next-generation ASI as it is highly selective for aldosterone synthase and spares the cortisol pathway in humans 1. The opportunity also brings the potential for combination with Farxiga and complements AstraZeneca’s strategy to provide added benefit across cardiorenal diseases, where there is a high unmet medical need. A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN) (BrigHTN). Available from: https://www.clinicaltrials.gov/ct2/show/NCT04519658?term=cin-107&draw=2&rank=2 [Last accessed 28 Dec 2022] The Expanse meets The Godfather in this space opera/sci-fi noir thriller about corporate greed, rebellion, and mankind’s survival among the stars. Board Member and President Syncorp Health, he brings over thirty (30) plus years of experience in Life Sciences & Health Care (LSHC) industry. Led the businesses in Strategic roles in companies like TCS LSHC, Wipro LSHC, Reliance, Biocon Ltd, Syneos Health & Cadila Pharmaceutical, experiences includes P&L leadership, building Offshoring, go-to-market strategies & Solutioning, Transitions, Transformation initiatives, & Quality Management services in Contract Research Organizations (CRO), BPO Life Sciences & Health Care (LSHC). CinCor holds the exclusive, worldwide licence to baxdrostat, which will remain in place following the transaction.

Dunkirk (2017)". Box Office Mojo. Archived from the original on 23 December 2017 . Retrieved 23 December 2017. Freeman MW, et al. (2022) Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension. NEJM, DOI: 10.1056/NEJMoa2213169. Kroll, Justin (8 October 2021). "Cillian Murphy Confirmed to Star As J. Robert Oppenheimer in Christopher Nolan's Next Film at Universal, Film Will Bow in July 2023". Deadline . Retrieved 8 October 2021. Inception (2010)". Box Office Mojo. Archived from the original on 8 August 2020 . Retrieved 20 August 2020. He is also a Senior Advisor to a number of multinational and domestic companies in the healthcare industry.Vos T, et al. (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet,390(10100):1211–59. With the balance of power shifting among powerful governments, secretive corporations, and radical cults, Colonel Graves and his allies face an impossible choice: Save the planet...or save themselves.

Centers for Disease Control and Prevention (CDC) [Internet]. A snapshot: Diabetes in the United States. Available from: https://www.cdc.gov/diabetes/library/socialmedia/infographics/diabetes.html [Last accessed 28 Dec 2022]. At Syncorp Health, multiple functions work in tandem to bring new therapies & devices to market, our Clinical function “Syncorp Health” earlier “Syncorp Clincare” works together with customers to build the tailored made solutions for success. And our unique solutions deliver the value across Small to Mid-size to Large customer continuum. The Lazarus Protocol is the first book in the SynCorp Saga, a sci-fi thriller series filled with action, betrayal, and political intrigue, spanning generations into the future.

Cliantha Research, full-service Clinical Research Organization (CRO), provides comprehensive and integrated offerings in Early Phase (BA-BE & Phase I), Late Phase (II-IV), Respiratory, Tobacco Research, Dermatology, Consumer Research, Research, Lab services, IVRT, Biometrics, Medical Services, Environmental Exposure Chambers (EECs). Board member and Chief Board Advisor at Syncorp Health, Dr. A. S. Arvind served as Chief Operating Officer of Clinigene, a subsidiary of Biocon Ltd. from 2000-2010 and was instrumental in planning, initiating and conducting clinical studies, clinical trials, biomarker identification studies, drug development, regulatory compliance both for in house as well as for domestic and multinational pharmaceuticals and biotech companies. Have combined work experience in core aspects of Development of Partnerships and Alliances with companies, Business management, Leads and Accounts generation, Promotional activities of company and Clinical Operations. Besieged on all sides, SynCorp’s Five Factions are in retreat. The rebels aim to destroy the Company to free mankind. But does mankind really want to be freed?

This announcement may include statements that are not statements of historical fact, or “forward-looking statements,” including with respect to AstraZeneca’s proposed acquisition of CinCor. Such forward-looking statements include, but are not limited to, the ability of AstraZeneca and CinCor to complete the transactions contemplated by the acquisition agreement, including the parties’ ability to satisfy the conditions to the consummation of the offer contemplated thereby and the other conditions set forth in the merger agreement, statements about the expected timetable for completing the transaction, AstraZeneca’s and CinCor’s beliefs and expectations and statements about the benefits sought to be achieved in AstraZeneca’s proposed acquisition of CinCor, the potential effects of the acquisition on both AstraZeneca and CinCor, the possibility of any termination of the acquisition agreement, as well as the expected benefits and success of baxdrostat and any combination product. These statements are based upon the current beliefs and expectations of AstraZeneca’s and CinCor’s management and are subject to significant risks and uncertainties. There can be no guarantees that the conditions to the closing of the proposed transaction will be satisfied on the expected timetable or at all or that baxdrostat or any combination product will receive the necessary regulatory approvals or prove to be commercially successful if approved. If underlying assumptions prove inaccurate or risks or uncertainties materialise, actual results may differ materially from those set forth in the forward-looking statements. Marketing Material such as Manuscript writing, abstract preparation, case study writing, poster preparation, writing of review articles, newsletterMarc de Garidel, CEO CinCor, said: “We are excited about the proposed acquisition of CinCor Pharma by AstraZeneca as we believe it offers the prospect of accelerating the development timeline and expanding the breadth of benefits patients with cardiorenal diseases might obtain from baxdrostat, if approved. CinCor is committed to ensuring a smooth transition of the development responsibilities to AstraZeneca once the acquisition is consummated. Thank you to all who have played, and will continue to play, essential roles in developing and evaluating baxdrostat as a potential novel treatment for cardiorenal diseases.” Strong team with International and Indian regulatory experience in writing regulatory documents for USFDA, EMA and DCGI submissions A Study to EvaluateCIN-107for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease. Available from: https://clinicaltrials.gov/ct2/show/NCT05432167?term=CIN-107&draw=2&rank=4 [Last accessed 28 Dec 2022]. Prior to joining Clinigene, he served as Consultant Physician at West Wales General Hospital, Wales UK between 1996-2000. He served as Medical Director of Mallya Hospital, Bangalore between 1990-1996 and was involved from concept to completion and running of the state-of-the-art tertiary referral hospital. He trained in the UK and India in Internal Medicine and Gastroenterology at St. Bartholomew Hospital and Broadgreen Hospital Liverpool, Victoria, St Martha’s and St John’s Medical College hospitals.